vimarsana.com
Home
Live Updates
Patient Profile: A 68-Year-Old Woman With HER2+ Metastatic Breast Cancer : vimarsana.com
Patient Profile: A 68-Year-Old Woman With HER2+ Metastatic Breast Cancer
Expert oncologist Virginia Kaklamani, MD, DSc, shares her perspectives on a patient case of HER2+ metastatic breast cancer (mBC) treated with multiple lines of therapy.
Related Keywords
,
Improving Outcomes ,
Breast Cancer ,
Translating Evidence ,
Clinical Practice ,
Year Old Woman With ,
Metastatic Breast Cancer ,
Virginia Kaklamani ,
Her2 Positive ,
Her2 Breast Cancer ,
Ild ,
Interstitial Lung Disease ,
Thp Therapy ,
Udocetaxel ,
Btrastuzumab ,
Pertuzumab ,
Cleopatra Trial ,
Cleopatra Regimen ,
Cleopatra Study ,
Trastuzumab Deruxtecan ,
Tdxd ,
T Dxd ,
Destiny Breast03 ,
Tdm1 ,
Trastuzumab Emtansine ,
Tucatinib ,
Capecitabine ,
Third Line Therapy ,
Third Line Treatment ,
Later Line Therapy ,
Her2climb ,
Her2climb Trial ,
Brain Mets ,
Brain Metastases ,
vimarsana.com © 2020. All Rights Reserved.